Cargando…
Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of severe type 2 diabetes (T2D). Human pancreatic islet transplantation confers a significant improvement in glycemic control and prevents life-threatening severe hypoglycemia in T1D patients. However, the shorta...
Autores principales: | Tahbaz, Meghan, Yoshihara, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382875/ https://www.ncbi.nlm.nih.gov/pubmed/34447354 http://dx.doi.org/10.3389/fendo.2021.716625 |
Ejemplares similares
-
Stem Cell-Derived Islets for Type 2 Diabetes
por: Salib, Andrew, et al.
Publicado: (2022) -
Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
por: Cayabyab, Fritz, et al.
Publicado: (2021) -
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
por: Naqvi, Raza Ali, et al.
Publicado: (2023) -
Human Pluripotent Stem Cells to Model Islet Defects in Diabetes
por: Balboa, Diego, et al.
Publicado: (2021) -
In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities
por: Halliez, Clémentine, et al.
Publicado: (2023)